Image_2_IL-6 Receptor Inhibition by Tocilizumab Attenuated Expression of C5a Receptor 1 and 2 in Non-ST-Elevation Myocardial Infarction.TIF by Hilde L. Orrem (5740313)

“…</p><p>Results: Our main findings were (i) Tocilizumab decreased C5aR1 and C5aR2 mRNA expression significantly (p < 0.001) and substantially (>50%) at day 2 and 3, whereas C3aR expression was unaffected. …”

Table_1_IL-6 Receptor Inhibition by Tocilizumab Attenuated Expression of C5a Receptor 1 and 2 in Non-ST-Elevation Myocardial Infarction.DOCX by Hilde L. Orrem (5740313)

“…</p><p>Results: Our main findings were (i) Tocilizumab decreased C5aR1 and C5aR2 mRNA expression significantly (p < 0.001) and substantially (>50%) at day 2 and 3, whereas C3aR expression was unaffected. …”

Microarray analyses of the transcriptome of diploid (D) and tetraploid (T) HCT116 cells treated with cisplatin, Chk1 inhibitor or the combination of both. by Ilio Vitale (82793)

XBP1 signalling is essential for alleviating mutant protein aggregation in ER-stress related skeletal disease - Fig 8 by Katarzyna A. Piróg (490536)

“…<i>Grp94</i> and <i>Manf</i> (downstream of ATF6 and/or XBP1) appear to be ATF6-dependent in EDM5 cartilage and are not affected by lack of XBP1 in <i>Xbp1</i>^Col2CreΔex2 <i>Matn3</i>^V194D tissue. …”

<i>Reck</i>^+/- fibroblasts show increased level of β1-integrin and enhanced contractile properties. by Jaime Gutiérrez (401710)

General patient characteristics. by Ekaterina A. Bryushkova (13360122)

Baseline clinical characteristics of patients. by Ekaterina A. Bryushkova (13360122)

Minimal dataset. by Ekaterina A. Bryushkova (13360122)

Experimental procedure and consumption of food and water during chronic PG-LPS infusion in mice. by Ichiro Matsuo (249122)

Immunohistochemistry for p-Met[Y1003] H-score results. by Raquel Muñoz (7405988)

Supplementary Material for: Early Hemodynamic Changes during Head-Up Tilt Table Testing Can Predict a Neurocardiogenic Response in an African-American Patient Population by Ho D. (4108837)

“…Positive responses were defined as the development of symptoms linked with a systolic blood pressure (BP) <90 mm Hg, heart rate <50 b.p.m. or sinus arrest >3 s. …”

The outcome timepoints and the mortality level of patients. by Ekaterina A. Bryushkova (13360122)

The dose-response curve evolves in time. by Federico Sevlever (8934533)

Stable knockdown of LINC00963 expression inhibited the invasion, migration, and tumor growth of the gastric cancer cell line, HGC-27. by Hong Du (117108)

Image_1_In Chagas disease, transforming growth factor beta neutralization reduces Trypanosoma cruzi infection and improves cardiac performance.tif by Roberto Rodrigues Ferreira (7109207)

“…For in vivo studies, 1D11 was administered in different schemes for acute and chronic phase models (Swiss mice infected with 10⁴ parasites from the Y strain and C57BL/6 mice infected with 10² parasites from the Colombian strain, respectively). …”

Western blot and zymogram analysis of DNASE1 and DNASE1L3 in urine and plasma samples from healthy human subjects and C57BL/6 mice. by Meihui Chen (1670020)

CHIR99021 promotes dorsal subventricular zone (dSVZ)-derived cortical oligodendrocyte (OL) regeneration following chronic hypoxia. by Kasum Azim (298800)

“…<b>(B)</b> Schematic representation of the results quantified in <b>(C-E)</b>. <b>(C-D)</b> CHIR99021 treatment following hypoxia leads to a decrease of YFP+ cells in the dSVZ <b>(C)</b>, paralleled by a concomitant increase in the cortex (<i>n</i> = 4 for hypoxic and <i>n</i> = 4 for CHIR99021) <b>(D)</b>. …”

Basal medium with autologous plasma (AP) or autologous platelet lysate (APL) results in loss of cell surface marker phenotype and impaired growth respectively. by Ana Leda F. Longhini (226617)

“…<b>(F):</b> concentration of harvested cells was determined 4 days after the cells were plated and shows a decrease in the growth rate when the cells were cultured in basal medium + APL compared to cells cultured in basal medium + FBS (<i>n</i> = 2). …”

<i>S</i>. <i>litura</i> growth and the levels of phytohormones JA and JA-Ile, transcripts <i>JAR1</i> and <i>CYP94B3</i>, and TPI activity after ABA treatment. by Yunting Lei (4256269)

Construction of the WGCNA Co-expression Network. by Jiyong Zhang (2498740)